A well thought through, clearly documented, and well-structured CDP is the foundation of a good clinical development, and an essential document when registering the intent to develop a new medicine or therapy.
Good CDPs anticipate the entire clinical development lifecycle and its goals, and make clear what documentation is required at each stage of development.
With extensive experience of clinical development, from Phase I through to post-marketing Phase IV studies, Trilogy is well-placed to assist with your CDPs.
Utilizing a Trilogy dedicated team to prepare not only the CDP, but also all the supporting regulatory documents (protocols, Informed Consent Forms, Investigator’s Brochures, study reports, subject narratives, Risk Management Plans, Periodic Safety Update Reviews, etc.) ensures consistency across your development programme.